Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014.

Author: BrombergJonathan S, DorganJoanne F, EngelsEric A, LynchCharles F, MagderLaurence S, MorrisCyllene R, NooneAnne-Michelle, PawlishKaren S, PfeifferRuth M

Paper Details 
Original Abstract of the Article :
BACKGROUND: Solid organ transplant recipients have an elevated risk of cancer. Quantifying deaths attributable to cancer can inform priorities to reduce cancer burden. METHODS: Linked transplantation and cancer registry data were used to identify incident cancers and deaths among solid organ transp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/31034602

データ提供:米国国立医学図書館(NLM)

Cancer's Shadow: A Growing Threat for Transplant Recipients

Organ transplantation is a life-saving procedure that offers a second chance for individuals with organ failure. However, transplant recipients face an increased risk of developing cancer. This research investigates the burden of cancer-related mortality among solid organ transplant recipients in the United States from 1987 to 2014. The study aimed to quantify the number of deaths attributable to cancer in this population and identify the most common types of cancer contributing to mortality.

A Complex Legacy: The Price of Survival

The study found that cancer contributed to approximately 13% of deaths among solid organ transplant recipients. Lung cancer, non-Hodgkin lymphoma, colorectal cancer, and kidney cancer were among the leading causes of cancer-related mortality. The study also revealed that cancer-attributable mortality increased with age at transplantation and time since transplantation.

Managing Cancer Risk in Transplant Recipients

This study emphasizes the importance of proactive cancer surveillance and prevention strategies for transplant recipients. Early detection and timely treatment are crucial for improving cancer outcomes in this vulnerable population. This is crucial because the results from this study suggest that cancer is a significant cause of death in this population, and therefore careful management of cancer risk is essential to improve the health and longevity of transplant recipients.

Dr. Camel's Conclusion

Imagine a camel caravan crossing a vast desert, leaving a trail in its wake. Just as a caravan's journey leaves a trace on the desert landscape, organ transplantation leaves a complex legacy for recipients, including an increased risk of developing cancer. This research, like a map highlighting potential dangers in the desert, underscores the importance of vigilant cancer screening and prevention strategies for transplant recipients.

Date :
  1. Date Completed 2020-05-12
  2. Date Revised 2023-12-10
Further Info :

Pubmed ID

31034602

DOI: Digital Object Identifier

NIHMS1020601

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.